drugset / Trial / NCT01548157
Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate pharmacokinetics and safety after oral administration of HCP1007 capsules and Rosuvastatin plus Omega-3.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-03
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HCP1007 | Unknown | — | Oral |
| Subject | Omega-3 fatty acids | Unknown | 1 g | Oral |
| Subject | Rosuvastatin | Small molecule | 10 mg | Oral |
Indications
No indication recorded.